Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 11:58 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2449–2472 of 3,580 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Coronary Artery Disease
Interventions: RXi System, Pressure Wire; Device
Lead sponsor: Acist Medical Systems; Industry
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 12
States / cities: La Jolla, California • Long Beach, California • Stanford, California + 8 more

Conditions: Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation
Interventions: Surgical Ablation, Cardioblate and Cryoflex hand held devices; Procedure · Device
Lead sponsor: Medtronic Cardiac Surgery; Industry
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 15
States / cities: Palo Alto, California • St. Helena, California • Hartford, Connecticut + 11 more

Conditions: Mental Disorder, Schizophrenia, Major Depressive Disorder, Bipolar I Disorder
Interventions: Placebo IEM tablet, Abilify MyCite®, D-Tect Patch; Drug · Device
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Garden Grove, California

Conditions: Post Operative Atrial Fibrillation
Interventions: CardiaMend with the Addition of Amiodarone; Combination Product
Lead sponsor: WakeMed Health and Hospitals; Other
Eligibility: 20 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Raleigh, North Carolina

Conditions: Ventricular Tachycardia, Cardiac Arrhythmia
Interventions: MRI scan; Other
Lead sponsor: Children's National Research Institute; Other
Eligibility: Not listed
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Head and Neck Cancer
Interventions: Cisplatin, Paclitaxel, Intensity-Modulated Radiation Therapy (IMRT) External Beam Radiation, Triple endoscopy and biopsy; Drug · Radiation · Procedure
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Necrobiosis Lipoidica
Interventions: Ruxolitinib; Drug
Lead sponsor: Aaron R. Mangold; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Restless Legs Syndrome
Interventions: Rotigotine; Drug
Lead sponsor: UCB BIOSCIENCES, Inc.; Industry
Eligibility: 13 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 5
States / cities: Los Angeles, California • Orange, California • Spring Hill, Florida + 2 more

Conditions: Lung Cancer, Lung; Nodule
Interventions: Robotic assisted bronchoscopy; Device
Lead sponsor: Noah Medical; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Chattanooga, Tennessee • Falls Church, Virginia

Conditions: Refractory Head and Neck Cancer, Squamous Cell Carcinoma, Skin, Carcinoma of the Breast, Malignant Melanoma
Interventions: HF10; Drug
Lead sponsor: Takara Bio Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 5
States / cities: The Bronx, New York • Portland, Oregon • Pittsburgh, Pennsylvania + 2 more

Conditions: Colorectal Cancer; Lung Cancer
Interventions: TATE and pembrolizumab, TAS-102 pill, Regorafenib Pill; Drug
Lead sponsor: Teclison Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Orange, California

Conditions: Disease or Lesions of the Anus, Rectum, or Distal Colon
Interventions: Transanal endoscopic surgical procedure; Device
Lead sponsor: Medrobotics Corporation; Other
Eligibility: 22 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Las Vegas, Nevada • New York, New York

Conditions: Prostate Cancer
Interventions: Androderm® 2.5mg, Androderm® 5.0mg, Androderm® 7.5mg; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older · Male only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Primary Ovarian Insufficiency
Interventions: Transdermal Estrogen; Drug
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 11 Years to 18 Years · Female only
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Lung Cancer, Lung Cancer Metastatic, Brain Metastases, Brain Metastases, Adult, Small-cell Lung Cancer, Small Cell Lung Carcinoma
Interventions: Stereotactic Radiosurgery, Cerebrospinal fluid collection; Radiation · Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Sweat Rate
Interventions: Sweat patch; Other
Lead sponsor: PepsiCo Global R&D; Industry
Eligibility: 13 Years and older · Female only
Enrollment: 516 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Oligometastatic Disease
Interventions: Stereotactic Radiosurgery (SRS), Chemotherapy; Radiation · Drug
Lead sponsor: Steven Burton; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Smoking
Interventions: Brief tobacco counseling; Behavioral
Lead sponsor: Oregon Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 2,637 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 3
States / cities: Jackson, Mississippi • New York, New York • Eugene, Oregon

Conditions: Brain and Central Nervous System Tumors, Kidney Cancer, Liver Cancer, Retinoblastoma, Sarcoma
Interventions: filgrastim, busulfan, etoposide, ifosfamide, melphalan, thiotepa, stem cell transplantation, tomotherapy, total marrow irradiation, Mesna, Whole lung radiation; Biological · Drug · Procedure + 1 more
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: Up to 70 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2016
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Menopause, Postmenopause, Premenopause, Cardiovascular Disease
Interventions: transdermal estradiol patch (Vivelle), oral estrogen (Estrace), progesterone (Prometrium); Drug
Lead sponsor: Northwestern University; Other
Eligibility: 47 Years to 55 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998 – 2005
U.S. locations: 2
States / cities: Chicago, Illinois • Seattle, Washington

Conditions: Contraception
Interventions: Gestodene/EE Patch (BAY86-5016); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 1,502 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 63
States / cities: Birmingham, Alabama • Glendale, Arizona • Phoenix, Arizona + 54 more

Conditions: Hemangioblastomas, Von Hippel Lindau Disease
Interventions: Avastin; Drug
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Patient
Interventions: Hyperspectral Endoscopy (HySE), White Light Endoscopy (WLE); Procedure · Device
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Carcinoma, Squamous Cell
Interventions: 5-fluorouracil, Calcipotriene; Drug
Lead sponsor: Melissa Pugliano-Mauro; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Search by objective public record fields.

Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement

Medtronic Terminate AF Study

A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion

Prevention of Post-OP AFib Using Combination of CardiaMend and Amiodarone

MRI Assessment of Arrythmia Ablation Lesions

Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer

Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica

Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome

Prospective Evaluation of the Tool-in-lesion Technology of the Galaxy System in Routine Clinical Practice

Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions

TATE and Pembrolizumab (MK3475) in mCRC and NSCLC

Post-Market Clinical Follow-Up to Access & Visualize the Anus, Rectum, & Distal Colon During Transanal Procedures

A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer

Primary Ovarian Insufficiency: Phenotype and Optimal Treatment

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

Normative Data for Sweating Rate, Sweat Sodium Concentration and Sweat Sodium Loss in Female Athlete

Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation

Tobacco Cessation Via Public Health Dental Clinics

MT2004-30: Tomotherapy for Solid Tumors

Midlife Cholesterol Study

Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles

Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease

Hyperspectral Endoscopy Imaging for the Early Detection of Precancerous Lesions in Average Risk Patients

Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC